MYL-1701P displayed similar efficacy, safety, and immunogenicity when compared with reference aflibercept to treat diabetic macular edema. Aflibercept is an intravitreal drug approved by the FDA for ...
The authors evaluate the effect and safety of biosimilar trastuzumab MYL-1401O in human epidermal growth factor receptor 2 (HER2)–positive early-stage (neoadjuvant and adjuvant therapy) and metastatic ...
MYL is in the strong medium-term uptrend since July. The fact, that the price has overshot the 25.75 target from the June low and not wasting any time reached to new highs, underscores the underlying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results